Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valeant Pharmaceuticals International Inc Names New Chairman


Thursday, 3 Jan 2013 08:00am EST 

Valeant Pharmaceuticals International Inc announced that Laizer D. Kornwasser has been named to Valeant's Executive Management Team and will assume the role of Executive Vice President/Company Group Chairman where he will be responsible for operations in Canada , U.S. Neurology and various other U.S. functions including managed care and distribution, effective February 1, 2013 . 

Company Quote

116.913
-8.917 -7.09%
31 Jul 2014